19 results
424B1
AXDX
Accelerate Diagnostics Inc
22 Jan 24
Prospectus with pricing info
9:59pm
the corrective actions requested by the FDA. On October 21, 2022, the Company also submitted a pre-submission package to the FDA, which is intended … discussions. The Company also cannot give any assurances as to the timing of the FDA’s response to the Company’s pre-submission package or whether
S-1/A
EX-1.1
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
by the information listed in Schedule II(c) hereto, taken together (collectively, the “Pricing Disclosure Package”), as of the Applicable Time, did … , as supplemented by and taken together with the Pricing Disclosure Package as of the Applicable Time, did not include any untrue statement of a material fact
S-1/A
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
, including promptly taking the corrective actions requested by the FDA. On October 21, 2022, the Company also submitted a pre-submission package to the FDA … package or whether the Company will be successful in obtaining 510(k) clearance for the Accelerate Arc Products.
Clinical trial data is typically
S-1
ymz 2rxq73gfo
13 Dec 23
IPO registration
5:30pm
8-K
rcxhj un5avjzw5kc
21 Oct 22
Other Events
4:02pm
8-K
EX-1.1
z5l8g62fgda7 swmkowx
23 Aug 22
Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
4:11pm
8-K
iot1qbq9t h1c3hp
2 Jul 13
Changes in Registrant's Certifying Accountant
12:00am
8-K
svvda e6bx
15 Aug 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
lsy7j 351sco33z
6 Dec 04
Entry into a Material Definitive Agreement
12:00am
424B3
r4nob6c1 q9mlksk4
22 Nov 96
Prospectus supplement
12:00am
- Prev
- 1
- Next